✦ LIBER ✦

Recombinant interleukin-2 treatment in patients with metastatic colorectal cancer: Effect on natural cytotoxicity

✍ Scribed by K. G. M. Park; S. D. Heys; J. B. Murray; P. D. Hayes; J. A. Ashby; C. R. Franks; O. Eremin

Publisher: Springer-Verlag
Year: 1992
Tongue: English
Weight: 744 KB
Volume: 35
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01741055

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients with disseminated

Treatment of patients with disseminated colorectal cancer with recombinant human alpha2-interferon. Studies on the immune system

✍ Stefan Einhorn; Jerzy Wasserman; Göran Lundell; Henric Blomgren; Björn Cedermark 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 606 KB

The influence of recombinant human alpha 2-interferon (alpha 2-IFN) therapy on various aspects of the immune system was studied in 18 patients with disseminated colorectal cancer. The IFN was given as continuous (20 X 10(6) units/m2 three times weekly) or intermittent (50 X 10(6) units/m2 daily for

Cytotoxic In vitro function in patients

Cytotoxic In vitro function in patients with metastatic renal cell carcinoma before and after alpha-2b-interferon therapy effects of activation with recombinant interleukin-2

✍ Cristina Feruglio; Renato Zambello; Livio Trentin; Pietro Bulian; Tiziano France 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

A phase I study of recombinant human int

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma

✍ A. Mittelman; M. Huberman; C. Puccio; B. Fallon; J. Tessitore; S. Savona; R. Eyr 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Preclinical data suggest synergy of interleukin-2 (IL-2) combined with alphainterferon (IFN). In addition, toxicities of IL-2 may be decreased by intermittent continuous infusion. The purpose of this trial was to determine the maximum tolerated dose (MTD) of recombinant IL-2 combined with alpha-IFN

Chemo-immunotherapy in patients with met

Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with decarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response

✍ Rut Isacson; Eli Kedar; Vivian Barak; Zulma Gazit; Oded Yurim; Inna Kalichman; H 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 576 KB

Anti-tumor effect of combined treatment

Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats

✍ Guido Rasi; Gianfranco Silecchia; Paola Sinibaldi-Vallebona; Erasmo Spaziani; Pa 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 625 KB

We studied the effect of combined chemo-immunotherapy, 5-FU followed by thymosin al (Toll) and interleukin-2 (IL-2) at low doses, on liver metastases from colorectal cancer, induced by splenic injection of DHD/KIZ cells (I ,2-dimethylhydrazineinduced colon adenocarcinoma) in syngeneic BDIX rats. The

Natural killer cells in children with ma

Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-α and interleukin-2 on natural killer cell function against tumor cell lines

✍ Carlos S. Alvarado; Harry W. Findley; Wing C. Chan; Robert S. Hnath; Aly Abdel-M 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

Natural killer (NK) cells and NK cell activity were determined in three groups (newly diagnosed [n = 211, on therapy [n = 211, and off therapy [n = 181) of children with various types of malignant solid tumors and in a control group (n = 26) by means of Leu-7 and Leu-llb monoclonal antibodies and a